RHA

Blue Wolf Capital Names David Hecht Operating Partner

Retrieved on: 
Monday, March 11, 2024
Professional Services, Health, Manufacturing, Managed Care, Finance, Banking, Machinery, Blue Wolf, Health care, Oliver Wyman, Princeton University, RHA, University, Disability studies, Acquisition, Investment, Nursing

Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle market private equity firm specializing in the industrial and healthcare sectors, today announced that David Hecht will be joining the firm as an operating partner specializing in healthcare investments.

Key Points: 
  • Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle market private equity firm specializing in the industrial and healthcare sectors, today announced that David Hecht will be joining the firm as an operating partner specializing in healthcare investments.
  • Mr. Hecht joins a roster of respected, seasoned operating partners at Blue Wolf who have deep experience in the healthcare and industrial sectors.
  • “David was a transformative member of the management team at RHA and will bring strategic thinking and creative problem-solving to his new role,” said Jeremy Kogler, Managing Partner at Blue Wolf Capital.
  • “At Blue Wolf, we remain focused on building our outstanding, integrated team of veteran operating partners and investment professionals.

KYOCERA AVX RELEASES NEW RES SERIES RADIAL-LEADED ALUMINUM ELECTROLYTIC CAPACITORS

Retrieved on: 
Tuesday, April 2, 2024
RES, RHA, RPA, REA, Electronics, Computer, REF, PCB, Avnet, REACH, Miniaturization, TTI, Arrow, Series, KYOCERA, Digi-Key, 1986 California Proposition 65

FOUNTAIN INN, S.C., April 2, 2024 /PRNewswire/ -- KYOCERA AVX, a leading global manufacturer of advanced electronic components engineered to accelerate technological innovation and build a better future, released the new RES Series radial-leaded aluminum electrolytic capacitors.

Key Points: 
  • The RES Series is the eighth series to join the extensive radial-leaded aluminum electrolytic capacitors portfolio that KYOCERA AVX released in February 2022.
  • That portfolio now offers four lines of wet aluminum electrolytic capacitors (the RES , REA , REF , and REH Series ), two lines of conductive polymer aluminum electrolytic capacitors (the RPA and RPF Series ), and two lines of hybrid aluminum electrolytic capacitors (the RHA and RHD Series ), as well as an even wider variety of part numbers available with commercial and industrial reliability levels and competitive pricing and lead times.
  • The new RES Series radial-leaded aluminum electrolytic capacitors are shipped in bulk packaging, and lead time for the series is currently 20–24 weeks.
  • For more information about KYOCERA AVX's new RES Series radial-leaded aluminum electrolytic capacitors, please visit https://www.kyocera-avx.com/products/aluminum-capacitors/res-series/ .

Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update

Retrieved on: 
Wednesday, February 28, 2024
Biotechnology, General Health, Pharmaceutical, Health, Therapy, RHA, Research, CMS, Fosun International, Education, MD, Investment, Physician, FDA, Marketing, Food, Growth, MBA, Adjustment, Collection, GAAP, Medicare, Webcast, Depreciation, Patient, Tax, OPEX, ASPEN, Lip, Torticollis, Ageing, American Academy, Pharmaceutical industry

Revance Therapeutics, Inc. (NASDAQ: RVNC), today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update.

Key Points: 
  • Revance Therapeutics, Inc. (NASDAQ: RVNC), today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update.
  • Excluding depreciation, amortization, stock-based compensation and restructuring charges, non-GAAP R&D expenses were $18.6 million and $65.5 million, respectively, for the fourth quarter and full year ended December 31, 2023.
  • Fourth quarter and full year 2023 RHA Collection revenue of $34.5 million and $128.6 million, respectively.
  • ET on February 28, 2024, to discuss its financial results and provide a corporate update.

Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook

Retrieved on: 
Monday, January 8, 2024
Biotechnology, General Health, Other Health, Health, Pharmaceutical, Patient, Fosun International, RHA, Collection, Dysphagia, Neurotoxin, FDA, Hubli railway division, Ageing, Torticollis, Therapy, Education, Death, Speech, COVID-19, Adjustment, Spasticity, Growth, Investment, Lip, Finance, PMA, GAAP, Hyaluronic acid

Revance Therapeutics , Inc. (NASDAQ:RVNC) today provided a corporate update as well as preliminary unaudited fourth quarter and full year 2023 financial results, 2024 guidance and financial outlook.

Key Points: 
  • Revance Therapeutics , Inc. (NASDAQ:RVNC) today provided a corporate update as well as preliminary unaudited fourth quarter and full year 2023 financial results, 2024 guidance and financial outlook.
  • We wish Dustin the best in his new endeavors.”
    Corporate Updates and Preliminary Q4 and FY 2023 Financial Results:
    Revance expects Q4 2023 preliminary unaudited DAXXIFY revenue to be between $23.5 million and $24.5 million.
  • Full year 2023 preliminary unaudited DAXXIFY revenue is expected to be between $83.5 million and $84.5 million.
  • Revance expects preliminary unaudited fourth quarter 2023 RHA Collection revenue to be between $34 million and $35 million, and full year preliminary unaudited 2023 RHA Collection revenue to be between $128 million and $129 million.

Schaeffler is "Making Next Possible" at CES 2024

Retrieved on: 
Monday, January 8, 2024
RHA, Family, Invention, University, Consumer Electronics Show, School, Student, Vertical, Motion, AI, DPMA, Patent, Torque, CASM, EUR, Transport, CES, Safety, CO2, German, Algorithm, Automation, Electric motor

FORT MILL, S.C., Jan. 8, 2024 /PRNewswire/ -- Schaeffler, a pioneering force in the field of motion technology, is returning to the Consumer Electronics Show (CES) in 2024 to demonstrate its most advanced motion technologies for the automotive, industrial and aerospace markets. The company's experiential exhibit will be located in the Central Plaza, booth CP-15, at the Las Vegas Convention Center from January 9-12, 2024.

Key Points: 
  • The company's experiential exhibit will be located in the Central Plaza, booth CP-15, at the Las Vegas Convention Center from January 9-12, 2024.
  • "CES serves as a unique platform to engage with the industry and showcase our latest technologies that drive, energize and generate motion."
  • Battery packs will be on display at CES 2024 as part of Schaeffler's medium-duty truck demonstrator.
  • Schaeffler is developing a range of mechatronics applications and will exhibit several examples of actuator innovations at CES 2024.

Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update

Retrieved on: 
Wednesday, November 8, 2023
Biotechnology, Pharmaceutical, Health, Medical Supplies, Adjustment, FDA, Research, NMPA, Therapy, Physician, SG, Invention, Collection, ASP, CCO, GAAP, R, Senior, Growth, ID, Commercial, Marketing, Webcast, Torticollis, Depreciation, Investment, Patient, RHA, Erica, Fosun Pharma, BLA, Filler (linguistics), Pharmaceutical industry, Video game, Cryptocurrency, Fine chemical, Q3

Revance Therapeutics, Inc. (RVNC), today reported financial results for the third quarter ended September 30, 2023 and provided a corporate update.

Key Points: 
  • Revance Therapeutics, Inc. (RVNC), today reported financial results for the third quarter ended September 30, 2023 and provided a corporate update.
  • Based on real-world learnings and customer feedback, Revance introduced new competitive pricing for DAXXIFY on September 1, 2023.
  • In September 2023, Revance revised its 2023 GAAP and Non-GAAP operating expense guidance to reflect the company's exit of the OPUL payments business.
  • ET on November 8, 2023, to discuss its financial results and provide a corporate update.

ComEd, Regional Partners Win $500,000 Federal Award to Advance Planning for Electric Vehicles in Northern Illinois

Retrieved on: 
Thursday, September 28, 2023
Climate Change, EV, Electric Vehicles, Automotive, Utilities, Research, Green Technology, Oil, Gas, Alternative Energy, Environment, Energy, Science, U.S. Department of Energy, Office of Inspector General, Commonwealth, Commonwealth Edison, National Renewable Energy Laboratory, Oak Ridge, Chicago Metropolitan Agency for Planning, Asthma, Travel, Partnership, Respiratory Health Association, U.S. Department of Defense Strategy for Operating in Cyberspace, Electricity, Chronic lung disease, GHG, Carbon, DOE, Mechanical, EVS, Exelon, Vehicle registration plates of Nepal, EXC, Argonne, CMAP, Climate change, RHA, Elevate, Growth, Transport, Air pollution, Renewable energy, C2C

The $500,000 federal award will support regional efforts to understand and inform strategies to reduce greenhouse gas emissions and boost the adoption of all-electric transportation options, including electric vehicles (EVs), to achieve a federal goal of net-zero carbon emissions by 2050.

Key Points: 
  • The $500,000 federal award will support regional efforts to understand and inform strategies to reduce greenhouse gas emissions and boost the adoption of all-electric transportation options, including electric vehicles (EVs), to achieve a federal goal of net-zero carbon emissions by 2050.
  • “With our partners, CMAP will be able to better inform its work around regional climate action planning to establish transportation emission reduction targets.
  • And most importantly, help our region attain its climate goals and substantial health benefits for our communities,” said CMAP Executive Director Erin Aleman.
  • ComEd also recently teamed up with regional partners, the Illinois Green Alliance and Elevate, to launch the new Building Performance Hub , an effort to advance sustainable building practices, and also supported by the DOE.

China Cycle 2023: CST debuts CST COREX two-wheeled tire product, promotes sustainable development for ESG project globally

Retrieved on: 
Sunday, May 7, 2023
Tired Business Men, Statistics, Table tennis rubber, MTB, RHA, CST, CO2, ESG, R, Conference, Clothing, Road, Renewable energy, Tire manufacturing, City, Recycling

CST has participated in the China Cycle for many years, and fully committed to leading the product development and trends of the bicycle industry.

Key Points: 
  • CST has participated in the China Cycle for many years, and fully committed to leading the product development and trends of the bicycle industry.
  • During the event, CST showcased its achievements and confidence at the CST ESG Sustainable Material Application Conference (the "Conference").
  • The newly launched two-wheeled tire CST COREX is the latest achievement of CST's application of ESG sustainable materials.
  • As the company continues to push forward ESG sustainable development, CST will further accelerate its roadmap build a green mobility eco-system with all partners.

China Cycle 2023: CST debuts CST COREX two-wheeled tire product, promotes sustainable development for ESG project globally

Retrieved on: 
Sunday, May 7, 2023
Tired Business Men, Statistics, Table tennis rubber, Multimedia, MTB, RHA, CST, CO2, ESG, R, LTD, Conference, Clothing, Road, Renewable energy, Tire manufacturing, City, Recycling

CST has participated in the China Cycle for many years, and fully committed to leading the product development and trends of the bicycle industry.

Key Points: 
  • CST has participated in the China Cycle for many years, and fully committed to leading the product development and trends of the bicycle industry.
  • During the event, CST showcased its achievements and confidence at the CST ESG Sustainable Material Application Conference (the "Conference").
  • The newly launched two-wheeled tire CST COREX is the latest achievement of CST's application of ESG sustainable materials.
  • As the company continues to push forward ESG sustainable development, CST will further accelerate its roadmap build a green mobility eco-system with all partners.

JTV® Launches 2023 Catch Your Breath® Campaign in Partnership with Respiratory Health Association®

Retrieved on: 
Thursday, April 20, 2023
Human, Pinterest, Partnership, Respiratory Health Association, Education, JTV, Catch, Woman, Research, Risk, Broken Frames, Call centre, RHA, Jewellery, Pharmaceutical industry

In this year’s Catch Your Breath campaign, customers will have the chance to support a worthy cause while shopping JTV’s exquisite jewelry pieces.

Key Points: 
  • In this year’s Catch Your Breath campaign, customers will have the chance to support a worthy cause while shopping JTV’s exquisite jewelry pieces.
  • During the campaign, JTV will introduce two beautiful butterfly keychains available for purchase with 50% of the selling price directly benefitting Respiratory Health Association’s research and educational programs.
  • “We are thrilled to partner with Respiratory Health Association for the fifth annual Catch Your Breath campaign,” said Tim Matthews, CEO of JTV.
  • "We are thrilled to partner with JTV once again for our annual Catch Your Breath campaign,” said Joel Africk, President and CEO at Respiratory Health Association.